US FDA Updates COVID-19 Vaccine Formulations, Revokes EUAs, ACIP Use Decision Next

Pathway in woods
Revocation of the EUAs means COVID-19 vaccines now will be marketed under a single pathway. (Shutterstock)

More from Vaccines

More from United States